VIRPAX PHARMACEUTICALS INC. - 15 min. - Technical analysis published on 07/13/2021 (GMT)
- 185
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 15 min.
- - Analysis generated on
- Status : TARGET REACHED
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Bullish
Technical indicators
78%
11%
11%
My opinion
Bullish above 5.70 USD
My targets
7.16 USD (+14.24%)
8.44 USD (+34.61%)
My analysis
VIRPAX PHARMACEUTICALS INC. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 5.70 USD. The next resistance located at 7.16 USD is the next bullish target to be reached. A bullish break in this resistance would boost the bullish momentum. The bullish movement could then continue towards the next resistance located at 8.44 USD.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
6.1
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
VIRPAX PHARMACEUTICALS INC. rating 6.27 USD. The price registered an increase of +39.33% on the session and was between 4.69 USD and 6.27 USD. This implies that the price is at +33.69% from its lowest and at 0% from its highest.4.69
6.27
6.27
The Central Gaps scanner detects a bullish gap which is a sign that buyers have taken the lead in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 15 min. chart of VIRPAX PHARMACEUTICALS INC. indicates that the overall trend is bullish. 71.43% of the signals given by moving averages are bullish. The overall trend is reinforced by the strong bullish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 14 technical indicators on 18 studied are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 80
Type : Neutral
Timeframe : 15 minutes
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 15 minutes
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 15 minutes
The analysis of the price chart with Central Patterns scanners does not return any result.
Central Candlesticks, the scanner specialised in Japanese candlesticks, detects a bullish signal that could support the hypothesis of a small rebound in the very short term:
Long white line
Type : Bullish
Timeframe : 15 minutes
ProTrendLines
S3
S2
S1
R1
R2
Price
| S3 | S2 | S1 | Price | R1 | R2 | |
|---|---|---|---|---|---|---|
| ProTrendLines | 5.14 | 5.39 | 6.11 | 6.27 | 7.17 | 8.44 |
| Change (%) | -18.02% | -14.04% | -2.55% | - | +14.35% | +34.61% |
| Change | -1.13 | -0.88 | -0.16 | - | +0.90 | +2.17 |
| Level | Major | Minor | Intermediate | - | Intermediate | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 4.01 | 4.11 | 4.31 | 4.41 | 4.61 | 4.71 | 4.91 |
| Camarilla | 4.42 | 4.45 | 4.47 | 4.50 | 4.53 | 4.56 | 4.58 |
| Woodie | 4.05 | 4.14 | 4.35 | 4.44 | 4.65 | 4.74 | 4.95 |
| Fibonacci | 4.11 | 4.23 | 4.30 | 4.41 | 4.53 | 4.60 | 4.71 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -1.26 | 1.49 | 2.95 | 5.70 | 7.16 | 9.91 | 11.37 |
| Camarilla | 3.26 | 3.65 | 4.03 | 4.42 | 4.81 | 5.19 | 5.58 |
| Woodie | -1.90 | 1.17 | 2.32 | 5.38 | 6.53 | 9.59 | 10.74 |
| Fibonacci | 1.49 | 3.10 | 4.09 | 5.70 | 7.31 | 8.30 | 9.91 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -0.36 | 1.67 | 3.11 | 5.14 | 6.58 | 8.61 | 10.05 |
| Camarilla | 3.60 | 3.91 | 4.23 | 4.55 | 4.87 | 5.19 | 5.50 |
| Woodie | -0.66 | 1.52 | 2.82 | 4.99 | 6.29 | 8.46 | 9.76 |
| Fibonacci | 1.67 | 3.00 | 3.81 | 5.14 | 6.47 | 7.28 | 8.61 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 65.38 | |
| MACD (12,26,9): | 0.1300 | |
| Directional Movement: | 23.56 | |
| AROON (14): | 71.43 | |
| DEMA (21): | 4.76 | |
| Parabolic SAR (0,02-0,02-0,2): | 4.69 | |
| Elder Ray (13): | 0.29 | |
| Super Trend (3,10): | 4.70 | |
| Zig ZAG (10): | 4.97 | |
| VORTEX (21): | 1.0700 | |
| Stochastique (14,3,5): | 58.13 | |
| TEMA (21): | 4.91 | |
| Williams %R (14): | -40.86 | |
| Chande Momentum Oscillator (20): | 0.43 | |
| Repulse (5,40,3): | -1.8900 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.3100 | |
| Courbe Coppock: | 20.23 |
| MA7: | 4.70 | |
| MA20: | 4.28 | |
| MA50: | 4.27 | |
| MA100: | 4.62 | |
| MAexp7: | 4.85 | |
| MAexp20: | 4.58 | |
| MAexp50: | 4.50 | |
| MAexp100: | 4.53 | |
| Price / MA7: | +33.40% | |
| Price / MA20: | +46.50% | |
| Price / MA50: | +46.84% | |
| Price / MA100: | +35.71% | |
| Price / MAexp7: | +29.28% | |
| Price / MAexp20: | +36.90% | |
| Price / MAexp50: | +39.33% | |
| Price / MAexp100: | +38.41% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
Don't forget to follow the news on VIRPAX PHARMACEUTICALS INC.. At the time of publication of this analysis, the latest news was as follows:
- Virpax Pharmaceuticals Provides Progress Update on Product Candidates
- Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications
- Virpax Pharmaceuticals to Present at LD Micro Invitational XI Event on Wednesday, June 9th at 4:30 PM ET
- Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent Developments
- Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering Efforts
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis VIRPAX PHARMACEUTICALS INC. - 15 min.